The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study
Open accessAbstract
Objectives: To examine: (1) changes in polypharmacy in 1997, 2002, 2007 and 2012 and; (2) changes in potentially inappropriate prescribing (PIP) prevalence and the relationship between PIP and polypharmacy in individuals aged ≥65 years over this period in Ireland. Methods: This repeated cross-sectional study using pharmacy claims data included all individuals eligible for the General Medical Services scheme in the former Eastern Health Board region of Ireland in 1997, 2002, 2007 and 2012 (range 338 025–539 752 individuals). Outcomes evaluated were prevalence of polypharmacy (being prescribed ≥5 regular medicines) and excessive polypharmacy (≥10 regular medicines) in all individuals and PIP prevalence in those aged ≥65 years determined by 30 criteria from the Screening Tool for Older Persons’ Prescriptions. Results: The prevalence of polypharmacy increased from 1997 to 2012, particularly among older individuals (from 17.8% to 60.4% in those aged ≥65 years). The adjusted incident rate ratio for polypharmacy in 2012 compared to 1997 was 4.16 (95% CI 3.23 to 5.36), and for excessive polypharmacy it was 10.53 (8.58 to 12.91). Prevalence of PIP rose from 32.6% in 1997 to 37.3% in 2012. High-dose aspirin and digoxin prescribing decreased over time, but long-term proton pump inhibitors at maximal dose increased substantially (from 0.8% to 23.8%). The odds of having any PIP in 2012 were lower compared to 1997 after controlling for gender and level of polypharmacy, OR 0.39 (95% CI 0.39 to 0.4). Conclusions: Accounting for the marked increase in polypharmacy, prescribing quality appears to have improved with a reduction in the odds of having PIP from 1997 to 2012. With growing numbers of people taking multiple regular medicines, strategies to address the related challenges of polypharmacy and PIP are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Gardner, W. P., Mulvey, E. P., & Shaw, E. C. (1995) · Psychological Bulletin · doi:10.1037//0033-2909.118.3.392 · Cited by 1,836
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & OMahony, D. (2008) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46072 · Cited by 1,506
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 875
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
Fialová, D. (2005) · JAMA · doi:10.1001/jama.293.11.1348 · Cited by 707
IMS Institute for Healthcare Informatics
Evans, R. (2014) · Nursing Standard · doi:10.7748/ns2014.04.28.32.30.s36 · Cited by 594
Adapting clinical guidelines to take account of multimorbidity
Guthrie, B., Payne, K., Alderson, P., McMurdo, M. E. T., & Mercer, S. W. (2012) · BMJ · doi:10.1136/bmj.e6341 · Cited by 530
Use of medications and polypharmacy are increasing among the elderly
Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivelä, S.-L., & Isoaho, R. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00411-0 · Cited by 509
Polypharmacy: Misleading, but manageable
Bushardt, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2468 · Cited by 489
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008
Hovstadius, B., Hovstadius, K., Åstrand, B., & Petersson, G. (2010) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-10-16 · Cited by 290
Inappropriate Medication Prescribing for Elderly Ambulatory Care Patients
Goulding, M. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.305 · Cited by 288
Less Is More: How Less Health Care Can Result in Better Health
Grady, D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.90 · Cited by 227
Cahir, C., Bennett, K., Teljeur, C., & Fahey, T. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12161 · Cited by 223
Self-citationGuthrie, B., McCowan, C., Davey, P., Simpson, C. R., Dreischulte, T., & Barnett, K. (2011) · BMJ · doi:10.1136/bmj.d3514 · Cited by 219
Payne, R. A., Abel, G. A., Avery, A. J., Mercer, S. W., & Roland, M. O. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12292 · Cited by 204
Haider, S. I., Johnell, K., Thorslund, M., & Fastbom, J. (2007) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45643 · Cited by 192
Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?
Gurwitz, J. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1957 · Cited by 190
Proton pump inhibitors: an update.
Vanderhoff, B., & Tahboub, R. (2002) · PubMed · Cited by 145
Hovstadius, B., Petersson, G., Hellström, L., & Ericson, L. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0165-5 · Cited by 80
Winding back the harms of too much medicine
Moynihan, R. N., Glasziou, P., Woloshin, S., Schwartz, L., Santa, J., & Godlee, F. (2013) · BMJ · doi:10.1136/bmj.f1271 · Cited by 79
Morgan, D. J., Wright, S. M., & Dhruva, S. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5444 · Cited by 78
Evidence-Based Medicine and the Hard Problem of Multimorbidity
Boyd, C. M., & Kent, D. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2658-z · Cited by 69
Cahir, C., Moriarty, F., Teljeur, C., Fahey, T. P., & Bennett, K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014552821 · Cited by 67
Self-citationPolypharmacy trends in office visits by the elderly in the United States, 1990 and 2000
Aparasu, R. R., Mort, J. R., & Brandt, H. (2005) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2005.06.004 · Cited by 66
Moriarty, F., Bennett, K., Fahey, T. P., Kenny, R. A., & Cahir, C. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1815-1 · Cited by 66
Self-citationOptimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?
Blanco‐Reina, E., Ariza‐Zafra, G., Ocaña‐Riola, R., León, M., & Bellido-Estévez, I. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1780-0 · Cited by 64
Gnjidic, D., Couteur, D. G. L., & Hilmer, S. N. (2014) · BMJ · doi:10.1136/bmj.g7013 · Cited by 52
The medicalisation of old age: Should be encouraged
Ebrahim, S. B. J. (2002) · BMJ · doi:10.1136/bmj.324.7342.861 · Cited by 51
Hunt, L. M., Kreiner, M., & Brody, H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1380 · Cited by 51
Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
Cahir, C., Fahey, T. P., Tilson, L., Teljeur, C., & Bennett, K. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-408 · Cited by 47
Self-citationPrice, S. D., Holman, C. D. J., Sanfilippo, F. M., & Emery, J. D. (2014) · Australian Journal on Ageing · doi:10.1111/ajag.12136 · Cited by 32
Goldacre, B. M., & Smeeth, L. L. (2014) · BMJ · doi:10.1136/bmj.g4745 · Cited by 27
National Use of Proton Pump Inhibitors From 2007 to 2011
Johansen, M. E., Huerta, T. R., & Richardson, C. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2900 · Cited by 27
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
“9% in people aged 65 years or older [49].”
BackgroundHospital admissions due to adverse drug reactions in the elderly. A meta-analysis
Oscanoa, T. J., Lizaraso, F., & Carvajal, A. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2225-3 · Cited by 382
Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
Delara, M., Murray, L., Jafari, B., Bahji, A., Goodarzi, Z., Kirkham, J., Chowdhury, M., & Seitz, D. P. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03279-x · Cited by 341
Association between polypharmacy and falls in older adults: a longitudinal study from England
Dhalwani, N. N., Fahami, R., Sathanapally, H., Seidu, S., Davies, M. J., & Khunti, K. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016358 · Cited by 261
Metadata
- Authors
- Moriarty, F., Hardy, C., Bennett, K., Smith, S. M., & Fahey, T.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2015-09
- Volume
- 5
- Issue
- 9
- Pages
- e008656
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2194138443
- Cited by
- 266
- References
- 35
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.